A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy

Key Points

• Efficacy of oncolytic virotherapy in pediatric cancers demonstrates promising results and immune responses.
• Overall safety profile shows manageable adverse events in the context of treatment.
• Systematic review conducted over a decade includes a comprehensive analysis of existing literature.
• Findings support the continued exploration of oncolytic virotherapy in pediatric oncology, indicating potential advancements.